CrushSCI.com
109.3平均天数
114中位天数
13最短天数
205最长天数
1242025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

131 天

NSAID Tolerance Can Be Restored in NECD Even in the Absence of Complete Remission of Urticaria

作者
Merve Hormet Igde; Pelin Korkmaz; Semra Demir; Osman Ozan Yegit; Derya Ünal; Merve Dilşad Atasever; Ayşe Feyza Aslan; Leyla Bölek; Selin Ece Güzel; Nevzat Kahveci; Mehmet Emin Sezgin; Şule Çelik Kamacı; Esra Kaya; Bircan Erden; Asli Gelincik展开收起
作者单位
1. Department of Internal Medicine Division of Allergy and Clinical Immunology Istanbul University Istanbul Faculty of Medicine Istanbul Türkiye展开收起
PDF源文件 DOI 网页
113 天

Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils

作者
Romana Vantur; Marusa Rihar; Ana Koren; Matija Rijavec; Peter Kopac; Urska Bidovec-Stojkovic; Renato Erzen; Peter Korosec展开收起
作者单位
1. University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; 2. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia展开收起
PDF源文件 DOI 网页
114 天

Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium

作者
Cancan Qi; Judith M. Vonk; Diana A. van der Plaat; Maartje A. E. Nieuwenhuis; F. Nicole Dijk; Dylan Aïssi; Valérie Siroux; H. Marike Boezen; Cheng-jian Xu; Gerard H. Koppelman展开收起
作者单位
1. Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2. GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 4. University Grenoble Alpes, Inserm, CNRS, Team of environmental epidemiology applied to Reproduction and Respiratory health, IAB (Institute for Advanced Biosciences), Grenoble, France; 5. Research Group of Bioinformatics and Computational Genomics, CiiM, Centre for individualized infection medicine, A Joint Venture Between Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 6. Department of Gastroenterology, Hepatology and Endocrinology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands展开收起
PDF源文件 DOI 网页
158 天

A novel ELISA method to determine human MrgX2 in chronic urticaria

作者
Yuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong He展开收起
作者单位
1. College of Pharmacy, Xi’an Jiaotong University, Xi’an, China展开收起
PDF源文件 DOI 网页
177 天

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

作者
A. Bédard; X. Basagaña; J. M. Anto; J. Garcia-Aymerich; P. Devillier; S. Arnavielhe; A. Bedbrook; G. L. Onorato; W. Czarlewski; R. Murray; R. Almeida; J. A. Fonseca; J. Correia da Sousa; E. Costa; M. Morais-Almeida; A. Todo-Bom; L. Cecchi; G. De Feo; M. Illario; E. Menditto; R. Monti; C. Stellato; M. T. Ventura; I. Annesi-Maesano; I. Bosse; J. F. Fontaine; N. Pham-Thi; M. Thibaudon; P. Schmid-Grendelmeier; F. Spertini; N. H. Chavannes; W. J. Fokkens; S. Reitsma; R. Dubakiene; R. Emuzyte; V. Kvedariene; A. Valiulis; P. Kuna; B. Samolinski; L. Klimek; R. Mösges; O. Pfaar; S. Shamai; R. E. Roller-Wirnsberger; P. V. Tomazic; D. Ryan; A. Sheikh; T. Haahtela; S. Toppila-Salmi; E. Valovirta; V. Cardona; J. Mullol; A. Valero; M. Makris; N. G. Papadopoulos; E. P. Prokopakis; F. Psarros; C. Bachert; P. W. Hellings; B. Pugin; C. Bindslev-Jensen; E. Eller; I. Kull; E. Melén; M. Wickman; G. De Vries; M. van Eerd; I. Agache; I. J. Ansotegui; S. Bosnic-Anticevich; A. A. Cruz; T. Casale; J. C. Ivancevich; D. E. Larenas-Linnemann; M. Sofiev; D. Wallace; S. Waserman; A. Yorgancioglu; D. Laune; J. Bousquet展开收起
作者单位
1. ISGlobal, Barcelona, Spain; 2. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 3. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 4. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5. UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; 6. KYomed INNOV, Montpellier, France; 7. CHU de Montpellier, Montpellier, France; 8. Medical Consulting Czarlewski, Levallois, France; 9. Research fellow, OPC, and Director, Cambridge, UK; 10. Medscript, Paraparaumu, New Zealand; 11. Faculdade de Medicina da Universidade do Porto, Lda Porto, Portugal; 12. MEDIDA, Lda, Porto, Portugal; 13. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; 14. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal; 15. Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 16. UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 17. Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal; 18. Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 19. SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; 20. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 21. Division for Health Innovation, Campania Region, Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; 22. CIRFF, Federico II University, Naples, Italy; 23. Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino, Mauriziano Hospital, Turin, Italy; 24. Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; 25. Medical School Saint Antoine, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Paris, France; 26. Allergist La Rochelle, La Rochelle, France; 27. Allergist, Reims, France; 28. Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France; 29. RNSA (Réseau National de Surveillance Aérobiologique), Brussieu, France; 30. Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 31. Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 32. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands; 33. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands; 34. Clinic of Chest Diseases, Immunology and Allergology, Medical Faculty, Vilnius University, Vilnius, Lithuania; 35. Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 36. Department of Pathology, Faculty of Medicine and Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania; 37. Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; 38. European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium; 39. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 40. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; 41. Center for Rhinology and Allergology, Wiesbaden, Germany; 42. Medical Faculty, CRI-Clinical Research International-Ltd, Institute of Medical Statistics, and Computational Biology, University of Cologne, Hamburg, Germany; 43. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany; 44. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 45. Department of ENT, Medical University of Graz, Graz, Austria; 46. Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK; 47. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 48. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 49. Department of Lung Diseases and Clinical Immunology, University of Turku, Terveystalo Allergy Clinic, Turku, Finland; 50. Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, ARADyAL Research Network, Barcelona, Spain; 51. Rhinology Unit, & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; 52. Pneumology and Allergy Department CIBERES and Clinical, & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain; 53. Allergy Unit “D Kalogeromitros”, 2nd Dpt of Dermatology and Venereology, National & Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece; 54. Division of Infection, & Respiratory Medicine, Royal Manchester Children’s Hospital Immunity, University of Manchester, Manchester, UK; 55. Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P&A Kyriakou,” University of Athens, Athens, Greece; 56. Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece; 57. Allergy Department, Athens Naval Hospital, Athens, Greece; 58. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium; 59. Sun Yat-sen University, International Airway Research Center, Guangzou, China; 60. Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; 61. Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden; 62. Academic Medical Center, Univ of Amsterdam, Dept of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, The Netherlands; 63. European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 64. Odense University Hospital, Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; 65. Thermofisher Scientific, Uppsala, Sweden; 66. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach´s Children and Youth Hospital, Södersjukhuset, Sweden; 67. Sachs’ Children and Youth Hospital, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 68. Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 69. Peercode BV, Geldermalsen, The Netherlands; 70. Transylvania University Brasov, Brasov, Romania; 71. Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; 72. Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, Australia; 73. Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; 74. WHO GARD Planning Group, Salvador, Brazil; 75. Division of Allergy/Immunology, University of South Florida, Tampa, USA; 76. Clinica Santa Isabel, Servicio de Alergia e Immunologia, Buenos Aires, Argentina; 77. Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; 78. Finnish Meteorological Institute (FMI), Helsinki, Finland; 79. Nova Southeastern University, Fort Lauderdale, USA; 80. Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Canada; 81. Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; 82. University Hospital, Montpellier, France; 83. INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; 84. Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France; 85. Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 86. Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany展开收起
PDF源文件 DOI 网页
130 天

A pragmatic randomized controlled trial to improve inhaler technique using mHealth

作者
Anna Vanoverschelde; Paulien van der Wel; Barbara Putman; Lies Lahousse展开收起
作者单位
1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium; 2. Department of Medicine and Department of Environmental Medicine, New York University School of Medicine, New York, USA展开收起
PDF源文件 DOI 网页

FAQ

Clinical and Translational Allergy审稿要多久?

截至2026-11-19,CrushSCI 收录了 Clinical and Translational Allergy 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 13 天(Highlights and recent developments in allergic diseases in EAACI journals (2019),2020-11-13 收稿,2020-11-26 录用),最慢一篇用了 205 天;平均 109.3 天,中位数 114 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。